Pallav L. Shah

14.8k total citations · 1 hit paper
222 papers, 6.2k citations indexed

About

Pallav L. Shah is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Pallav L. Shah has authored 222 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Pulmonary and Respiratory Medicine, 33 papers in Physiology and 18 papers in Surgery. Recurrent topics in Pallav L. Shah's work include Chronic Obstructive Pulmonary Disease (COPD) Research (97 papers), Respiratory Support and Mechanisms (66 papers) and Pleural and Pulmonary Diseases (44 papers). Pallav L. Shah is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (97 papers), Respiratory Support and Mechanisms (66 papers) and Pleural and Pulmonary Diseases (44 papers). Pallav L. Shah collaborates with scholars based in United Kingdom, Netherlands and United States. Pallav L. Shah's co-authors include Felix Herth, Dirk‐Jan Slebos, Samuel V. Kemp, Arschang Valipour, Nicholas S Hopkinson, Eric Lim, Zaid Zoumot, Peter J. Barnes, Katie Adams and Liza Edmonds and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Pallav L. Shah

202 papers receiving 6.0k citations

Hit Papers

Immuno-proteomic profiling reveals aberrant immune cell r... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pallav L. Shah United Kingdom 44 4.9k 945 729 400 385 222 6.2k
Louis Irving Australia 42 3.5k 0.7× 753 0.8× 710 1.0× 639 1.6× 886 2.3× 213 5.8k
Bernard Maître France 36 2.5k 0.5× 587 0.6× 535 0.7× 744 1.9× 255 0.7× 152 4.9k
Fabien Maldonado United States 40 4.1k 0.8× 712 0.8× 1.3k 1.8× 129 0.3× 419 1.1× 257 5.7k
David Shitrit Israel 35 2.0k 0.4× 508 0.5× 990 1.4× 249 0.6× 356 0.9× 183 3.7k
Marion Delcroix Belgium 48 9.6k 1.9× 632 0.7× 1.3k 1.8× 693 1.7× 239 0.6× 266 11.7k
Lonny Yarmus United States 38 3.6k 0.7× 281 0.3× 1.1k 1.4× 290 0.7× 471 1.2× 204 4.8k
Yeon‐Mok Oh South Korea 40 3.8k 0.8× 1.4k 1.4× 616 0.8× 851 2.1× 183 0.5× 358 5.9k
Marco Confalonieri Italy 40 4.0k 0.8× 761 0.8× 425 0.6× 443 1.1× 173 0.4× 185 6.1k
Man Pyo Chung South Korea 41 3.7k 0.8× 899 1.0× 945 1.3× 186 0.5× 447 1.2× 230 5.5k
George A. Eapen United States 32 2.3k 0.5× 263 0.3× 618 0.8× 368 0.9× 422 1.1× 100 3.3k

Countries citing papers authored by Pallav L. Shah

Since Specialization
Citations

This map shows the geographic impact of Pallav L. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pallav L. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pallav L. Shah more than expected).

Fields of papers citing papers by Pallav L. Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pallav L. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pallav L. Shah. The network helps show where Pallav L. Shah may publish in the future.

Co-authorship network of co-authors of Pallav L. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Pallav L. Shah. A scholar is included among the top collaborators of Pallav L. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pallav L. Shah. Pallav L. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Orton, Christopher M., Justin Garner, Anand Tana, et al.. (2024). Feasibility of continuous bronchoscopy during exercise in the assessment of large airway movement in healthy subjects. Journal of Applied Physiology. 136(6). 1429–1439. 2 indexed citations
3.
Mullol, Joaquim, Vibeke Backer, Jannis Constantinidis, et al.. (2024). Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma. Rhinology Journal. 0(0). 0–0. 2 indexed citations
4.
Benn, Bryan S., William B. Tisol, Onkar V. Khullar, et al.. (2024). Spot On. SHILAP Revista de lepidopterología. 3(1). 100131–100131. 1 indexed citations
5.
Ernst, Armin, Charles A. Read, John G. Buckley, et al.. (2022). Adult Bronchoscopy Training: Current State and Suggestions for the Future: CHEST Expert Panel Report. The Indian Journal of Chest Diseases and Allied Sciences. 58(1). 70–73. 3 indexed citations
6.
Goorsenberg, Annika W.M., Annemiek Dijkhuis, Barbara Dierdorp, et al.. (2021). Metabolic differences between bronchial epithelium from healthy individuals and patients with asthma and the effect of bronchial thermoplasty. Journal of Allergy and Clinical Immunology. 148(5). 1236–1248. 35 indexed citations
7.
Born, Jannis, David Beymer, Deepta Rajan, et al.. (2021). On the role of artificial intelligence in medical imaging of COVID-19. Patterns. 2(6). 100269–100269. 38 indexed citations
8.
Gregson, Florence K. A., Natalie A. Watson, Christopher M. Orton, et al.. (2021). Comparing aerosol concentrations and particle size distributions generated by singing, speaking and breathing. Aerosol Science and Technology. 55(6). 681–691. 136 indexed citations
9.
Bartlett, Emily, Sujal R. Desai, Saeed Mirsadraee, et al.. (2019). MA10.10 Uptake in Lung Cancer Screening – Does CT Location Matter? A Pilot Study Comparison of a Mobile and Hospital Based CT Scanner. Journal of Thoracic Oncology. 14(10). S289–S289. 2 indexed citations
10.
Slebos, Dirk‐Jan, David Breen, James E. Coad, et al.. (2017). Safety and Histological Effect of Liquid Nitrogen Metered Spray Cryotherapy in the Lung. American Journal of Respiratory and Critical Care Medicine. 196(10). 1351–1352. 23 indexed citations
11.
Garner, Justin, Samuel V. Kemp, Tudor Toma, et al.. (2016). Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up Study. American Journal of Respiratory and Critical Care Medicine. 194(4). 519–521. 37 indexed citations
13.
Faisal, Azmy, Zaid Zoumot, Pallav L. Shah, et al.. (2015). Effective Bronchoscopic Lung Volume Reduction Accelerates Exercise Oxygen Uptake Kinetics in Emphysema. CHEST Journal. 149(2). 435–446. 25 indexed citations
14.
15.
Fiterman, Jussara, et al.. (2013). Bronchial thermoplasty: long term effectiveness and safety in patients with severe persistent asthma. Journal of Allergy and Clinical Immunology. 1 indexed citations
16.
Beirne, Paul, P. Pantelidis, P. Charles, et al.. (2009). Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. European Respiratory Journal. 34(6). 1376–1382. 55 indexed citations
17.
Paredi, Paolo, Sergei A. Kharitonov, David J. Leak, et al.. (2000). Exhaled Ethane Is Elevated in Cystic Fibrosis and Correlates with Carbon Monoxide Levels and Airway Obstruction. American Journal of Respiratory and Critical Care Medicine. 161(4). 1247–1251. 81 indexed citations
18.
Shah, Pallav L., DM Geddes, Richard Conway, et al.. (1997). An evaluation of two aerosol delivery systems for rhDNase. European Respiratory Journal. 10(6). 1261–1266. 26 indexed citations
19.
Shah, Pallav L., Andrew Bush, H J Fuchs, et al.. (1995). Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment. European Respiratory Journal. 8(6). 954–958. 67 indexed citations
20.
Shah, Pallav L., Sandra Scott, DM Geddes, & Mark E. Hodson. (1995). Two years experience with recombinant Human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respiratory Medicine. 89(7). 499–502. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026